🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/04/2002 | 71,90 | 73,47 | 67,86 | 69,28 | -3,39% | 7,81% | 158.937 |
| 16/04/2002 | 67,56 | 71,72 | 67,56 | 71,72 | +5,45% | 6,15% | 110.981 |
| 15/04/2002 | 68,20 | 68,95 | 67,00 | 68,01 | -0,66% | 2,85% | 141.518 |
| 12/04/2002 | 69,28 | 69,81 | 68,08 | 68,46 | -0,54% | 2,49% | 221.802 |
| 11/04/2002 | 68,31 | 70,52 | 67,97 | 68,83 | +0,71% | 3,73% | 146.300 |
| 10/04/2002 | 66,03 | 68,87 | 66,03 | 68,35 | +3,34% | 4,31% | 141.438 |
| 09/04/2002 | 68,42 | 69,47 | 65,20 | 66,14 | -3,44% | 6,24% | 72.295 |
| 08/04/2002 | 67,60 | 69,25 | 64,01 | 68,50 | +0,55% | 7,75% | 121.668 |
| 05/04/2002 | 70,26 | 71,12 | 64,83 | 68,12 | -6,67% | 8,95% | 151.377 |
| 04/04/2002 | 73,74 | 74,04 | 72,20 | 72,99 | -1,02% | 2,49% | 118.061 |
| 03/04/2002 | 73,18 | 75,20 | 71,94 | 73,74 | +0,77% | 4,45% | 106.279 |
| 02/04/2002 | 73,70 | 75,80 | 72,24 | 73,18 | -2,20% | 4,82% | 173.819 |
| 01/04/2002 | 73,06 | 75,31 | 72,24 | 74,82 | +1,37% | 4,20% | 133.076 |
| 28/03/2002 | 72,84 | 74,78 | 72,76 | 73,81 | -0,05% | 2,77% | 171.361 |
| 27/03/2002 | 74,90 | 76,73 | 71,87 | 73,85 | -1,25% | 6,50% | 190.517 |
| 26/03/2002 | 70,97 | 75,20 | 70,97 | 74,78 | +5,16% | 5,96% | 378.762 |
| 25/03/2002 | 69,66 | 72,39 | 69,25 | 71,12 | +2,98% | 4,51% | 163.720 |
| 22/03/2002 | 68,50 | 71,45 | 68,23 | 69,06 | +2,22% | 4,70% | 270.880 |
| 21/03/2002 | 67,19 | 68,80 | 64,79 | 67,56 | +9,26% | 5,96% | 257.388 |
| 20/03/2002 | 62,69 | 62,84 | 61,31 | 61,83 | -1,96% | 2,45% | 25.701 |
| 19/03/2002 | 62,69 | 63,44 | 62,51 | 63,07 | +0,60% | 1,49% | 42.239 |
| 18/03/2002 | 62,17 | 63,07 | 60,75 | 62,69 | +0,54% | 3,73% | 63.880 |
| 15/03/2002 | 59,85 | 63,03 | 59,33 | 62,36 | +3,54% | 6,19% | 88.138 |
| 14/03/2002 | 60,75 | 63,37 | 59,74 | 60,22 | -1,17% | 5,98% | 128.908 |
| 13/03/2002 | 61,76 | 61,76 | 60,26 | 60,94 | -0,73% | 2,42% | 220.653 |
| 12/03/2002 | 59,89 | 61,65 | 59,70 | 61,38 | +1,61% | 3,25% | 96.821 |
| 11/03/2002 | 60,64 | 61,46 | 59,70 | 60,41 | +0,50% | 2,90% | 113.172 |
| 08/03/2002 | 57,79 | 60,11 | 57,60 | 60,11 | +5,38% | 4,34% | 159.098 |
| 07/03/2002 | 56,33 | 58,02 | 56,11 | 57,04 | +0,26% | 3,39% | 75.181 |
| 06/03/2002 | 55,77 | 57,57 | 55,58 | 56,89 | +2,01% | 3,56% | 99.707 |